Market Overview

RTI Biologics, Inc. (NASDAQ: RTIX)

2.65 -0.02 (-0.75%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
Pre-Market
EPS:
REV:
0.01
69.741M



Q4 2019
Pre-Market
EPS:
REV:
0.04
71.216M



Q3 2019
Pre-Market
EPS:
REV:
0.03
69.064M



Q2 2019
Pre-Market
EPS:
REV:
0.03
70.685M
-0.01
81.24M
0.01
82.307M
200%
1.31%
Q1 2019
Pre-Market
EPS:
REV:
0.01
69.89M
-0.01
69.02M
0.01
69.741M
200%
1.04%
Q4 2018
Pre-Market
EPS:
REV:
0.03
70.816M
0.01
70.34M
0.04
71.216M
300%
1.25%
Q3 2018
Pre-Market
EPS:
REV:
0.01
66.688M
0.01
68.64M
0.03
69.064M
200%
0.62%
Q2 2018
Pre-Market
EPS:
REV:
0.02
72.12M
0.01
70.19M
0.03
70.685M
200%
0.71%
Q1 2018
Pre-Market
EPS:
REV:

69.939M
0.01
68.73M
0.01
69.89M

1.69%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!